Related Experiment Video
Updated: May 8, 2026
09:37
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Coagulation abnormalities in the cirrhotic patient.
Jimena Muciño-Bermejo1, Raúl Carrillo-Esper, Misael Uribe
1Intensive Care.
Annals of Hepatology
|September 11, 2013
Summary
Cirrhosis disrupts the normal blood clotting process by altering coagulation factors. This review examines the pathophysiology, diagnosis, and treatment of these clotting abnormalities in liver disease patients.
Area of Science:
- Hematology
- Hepatology
- Coagulation Science
Background:
- The liver is central to hemostasis, synthesizing coagulation factors and fibrinolytic proteins.
- Cirrhosis leads to portal hypertension and endothelial dysfunction, altering coagulation.
- Liver disease patients exhibit an imbalanced procoagulant/anticoagulant state.
Purpose of the Study:
- To review the pathophysiological basis of coagulation abnormalities in cirrhosis.
- To discuss diagnostic and therapeutic strategies for cirrhotic patients.
- To analyze the impact of these strategies on clinical outcomes.
Main Methods:
- Review of existing literature on liver disease and coagulation.
- Analysis of pathophysiological mechanisms of hemostasis in cirrhosis.
- Evaluation of diagnostic and therapeutic approaches.
Main Results:
- Cirrhosis significantly alters the balance of clotting factors.
- Traditional coagulation tests may be unreliable in cirrhotic patients.
- Standard transfusional strategies may not be suitable for this population.
Conclusions:
- Coagulation abnormalities in cirrhosis are complex and multifactorial.
- Specialized diagnostic and therapeutic approaches are needed.
- Optimizing management can improve clinical outcomes for cirrhotic patients.
Related Concept Videos
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...